Search

Your search keyword '"T cell epitopes"' showing total 474 results

Search Constraints

Start Over You searched for: Descriptor "T cell epitopes" Remove constraint Descriptor: "T cell epitopes"
Sorry, I don't understand your search. ×
474 results on '"T cell epitopes"'

Search Results

2. T Cell Peptide Prediction, Immune Response, and Host–Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects.

Catalog

Books, media, physical & digital resources

3. Preclinical immunogenicity risk assessment of biotherapeutics using CD4 T cell assays.

4. Regional Variation of the CD4 and CD8 T Cell Epitopes Conserved in Circulating Dengue Viruses and Shared with Potential Vaccine Candidates.

5. Cross-Reactivity Assessment of Vaccine-Derived SARS-CoV-2 T Cell Responses against BA.2.86 and JN.1.

6. To stay or not to stay intact as an allergen: the endolysosomal degradation assay used as tool to analyze protein immunogenicity and T cell epitopes

7. Identification of T cell and linear B cell epitopes on African horse sickness virus serotype 4 proteins VP1-1, VP2, VP4, VP7 and NS3.

8. Bioinformatic Approach of B and T Cell Epitopes of PLD and CP40 Proteins of Corynebacterium pseudotuberculosis ovis Mexican Isolate 2J-L towards a Peptide-Based Vaccine.

9. Early protective effect of a ("pan") coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration.

10. Design and generation of mRNAs encoding conserved regions of SARS-CoV-2 ORF1ab for T cell-mediated immune activation.

11. iTCep: a deep learning framework for identification of T cell epitopes by harnessing fusion features.

12. Direct identification of HLA class I and class II-restricted T cell epitopes in pancreatic cancer tissues by mass spectrometry

13. Early protective effect of a ('pan') coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration

14. Differential T cell immune responses to deamidated adeno-associated virus vector

15. A comprehensive study of epitopes and immune reactivity among Plasmodium species

16. Nanoparticle Vaccine Triggers Interferon-Gamma Production and Confers Protective Immunity against Porcine Reproductive and Respiratory Syndrome Virus.

17. Immunoinformatic approach to design T cell epitope-based chimeric vaccine targeting multiple serotypes of dengue virus.

18. A multiepitope vaccine candidate against infectious bursal disease virus using immunoinformatics-based reverse vaccinology approach

19. Direct identification of HLA class I and class II-restricted T cell epitopes in pancreatic cancer tissues by mass spectrometry.

20. Knowledge of SARS-CoV-2 Epitopes and Population HLA Types Is Important in the Design of COVID-19 Vaccines.

21. Not all T cell epitopes are equally desired: a review of in silico tools for the prediction of cytokine-inducing potential of T-cell epitopes.

23. Identification of promising CD8 and CD4 T cell epitopes for peptide vaccine formulation against SARS-CoV-2.

24. Design of Vaccine Targeting Zika Virus Polyprotein by Immunoinformatics Technique.

25. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations

26. Norovirus-Specific CD8+ T Cell Responses in Human Blood and TissuesSummary

27. A comprehensive study of epitopes and immune reactivity among Plasmodium species.

28. The interdependence of machine learning and LC-MS approaches for an unbiased understanding of the cellular immunopeptidome.

29. In silico identification and modification of T cell epitopes in pertussis antigens associated with tolerance

30. Development of Hypoallergenic Derivatives of Cra a 1 with B Cell Epitope Deletion and T Cell Epitope Retention.

31. In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein.

32. Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis.

33. NetMHCphosPan - Pan-specific prediction of MHC class I antigen presentation of phosphorylated ligands

34. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals

35. Impact of in vitro evolution on antigenic diversity of Mycobacterium bovis bacillus Calmette-Guerin (BCG)

36. Knowledge of SARS-CoV-2 Epitopes and Population HLA Types Is Important in the Design of COVID-19 Vaccines

37. Design of Epitope Based Vaccine for Dengue Virus Using Immunoinformatic Approach.

38. Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2.

39. Immunological and Symptomatic Effects of Oral Intake of Transgenic Rice Containing 7 Linked Major T-Cell Epitopes from Japanese Cedar Pollen Allergens.

40. Influenza Virus-Derived CD8 T Cell Epitopes: Implications for the Development of Universal Influenza Vaccines.

41. Immunogenicity risk assessment for biotherapeutics through in vitro detection of CD134 and CD137 on T helper cells

42. Designing of cytotoxic and helper T cell epitope map provides insights into the highly contagious nature of the pandemic novel coronavirus SARS-CoV-2

43. Immunogenicity of Immunotoxins Containing Pseudomonas Exotoxin A: Causes, Consequences, and Mitigation

44. Prediction of T cell and B cell epitopes of the 22-, 47-, 56-, and 58-kDa proteins of Orientia tsutsugamushi

45. In silico prediction of the epitopes for the immunogenic proteins present in Mycobacterium avium subsp. paratuberculosis

46. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications

47. Prediction and Identification of Epitopes in the Emy162 Antigen of Echinococcus multilocularis.

48. Immunogenicity of Immunotoxins Containing Pseudomonas Exotoxin A: Causes, Consequences, and Mitigation.

49. Experimental analysis of T cell epitopes for designing liver cancer vaccine predicted by system-level immunoinformatics approach.

50. SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron